Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam

被引：13
|
作者：
Schimmenti, A. [1 ]
Brunetti, E. [1 ,2 ]
Seminari, E. [2 ]
Mariani, B. [3 ]
Cambieri, P. [3 ]
Orsolini, P. [2 ,4 ]
机构：
[1] Univ Pavia, Unita Malattie Infett & Trop Epatol, Dipartimento Sci Clinicochirurg & Diagnost & Pedi, Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Unita Malattie Infett & Trop, Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, Microbiol & Virol, Pavia, Italy
[4] Univ Pavia, Dipartimento Med Interna & Terapia Med, Pavia, Italy
来源：
CASE REPORTS IN INFECTIOUS DISEASES | 2018年 / 2018卷
关键词：
D O I：
10.1155/2018/1854805
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Antimicrobial resistance in Gram-negative bacteria, particularly Enterobacteriaceae, has become a leading cause of morbidity and mortality and a serious public health concern. Gram-negative bacteria carrying extended-spectrum beta-lactamase (ESBL) enzymes now represent a significant proportion of all bacteria isolated from different countries worldwide. Furthermore, the increasing number of isolates carrying carbapenemases in recent years includes multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria. Here, we describe what, to our knowledge, is the first case of a patient with a prosthetic joint infection from carbapenemase-resistant Klebsiella pneumoniae (CRKP) successfully treated with ceftazidime-avibactam in Italy.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    Hosbul, Tugrul
    Aydogan, Canset Nur
    Kaya, Sinem
    Bedir, Orhan
    Gumral, Ramazan
    Albay, Ali
    MIKROBIYOLOJI BULTENI, 2022, 56 (02): : 218 - 229
  • [42] Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam
    Alghoribi, Majed F.
    Alqurashi, Moayad
    Okdah, Liliane
    Alalwan, Bassam
    AlHebaishi, Yahya S.
    Almalki, Abdulmajeed
    Alzayer, Maha A.
    Alswaji, Abdulrahman A.
    Doumith, Michel
    Barry, Mazin
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Klebsiella pneumoniae carbapenemase variant 44 acquires ceftazidime-avibactam resistance by altering the conformation of active-site loops
    Sun, Zhizeng
    Lin, Hanfeng
    Hu, Liya
    Neetu, Neetu
    Sankaran, Banumathi
    Wang, Jin
    Prasad, B. V. Venkataram
    Palzkill, Timothy
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (01)
  • [44] Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis
    Krithika, Varshini M.
    Ganesan, Vithiya
    Rajendran, T.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 49
  • [45] Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae
    Perez-Nadales, Elena
    Fernandez-Ruiz, Mario
    Natera, Alejandra M.
    Gutierrez-Gutierrez, Belen
    Mularoni, Alessandra
    Russelli, Giovanna
    Pierrotti, Ligia Camera
    Freire, Maristela Pinheiro
    Falcone, Marco
    Tiseo, Giusy
    Tumbarello, Mario
    Raffaelli, Francesca
    Abdala, Edson
    Bodro, Marta
    Gervasi, Elena
    Farinas, Maria Carmen
    Seminari, Elena M.
    Caston, Juan Jose
    Marin-Sanz, Juan Antonio
    Galvez-Soto, Victor
    Rana, Meenakshi M.
    Loeches, Belen
    Martin-Davila, Pilar
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    Aguado, Jose Maria
    Martinez-Martinez, Luis
    Torre-Cisneros, Julian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (07) : 1022 - 1034
  • [46] Off-Label Use of Ceftazidime-Avibactam in a Premature Infant With Multidrug-Resistant Klebsiella pneumoniae Infection: A Case Report
    Nascimento, Allan da S.
    Passaro, Marcos F.
    Silva, Priscilla S. de S.
    Rodriguez, Sergio F.
    Martins, Marilene K.
    Oliveira, Stefane Cristina P.
    Moriel, Patricia
    Visacri, Marilia B.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 1020 - 1025
  • [47] A Case Report of Invasive Klebsiella pneumoniae Liver Abscess Syndrome Treated with Ceftazidime-Avibactam in Combination with Meropenem
    Yang, Mengying
    Wang, Baogui
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4161 - 4165
  • [48] Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
    Kong, Wenqiang
    Yang, Xueting
    Shu, Yunfeng
    Li, Shiqin
    Song, Bihui
    Yang, Kun
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [49] Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
    Shields, Ryan K.
    Nguyen, M. Hong
    Chen, Liang
    Press, Ellen G.
    Potoski, Brian A.
    Marini, Rachel V.
    Doi, Yohei
    Kreiswirth, Barry N.
    Clancy, Cornelius J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (08)
  • [50] The Klebsiella pneumoniae carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam
    Garsevanyan, Sona
    Barlow, Miriam
    ANTIBIOTICS-BASEL, 2024, 13 (01):
12345